Header cover image

South Korean (KOSPI) Pharma Industry Analysis

UpdatedFeb 01, 2025
DataAggregated Company Financials
Companies101
  • 7D0.4%
  • 3M-4.7%
  • 1Y10.0%
  • YTD2.2%

Over the last 7 days, the Pharma industry has remained flat. As for the the longer term, the industry is up 11% over the past 12 months. Looking forward, earnings are forecast to grow by 31% annually.

Industry Valuation and Performance

Has the South Korean Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 01 Feb 2025₩55.8t₩29.6t₩1.0t11.7x54.6x1.9x
Mon, 30 Dec 2024₩52.7t₩29.4t₩989.8b12x53.2x1.8x
Wed, 27 Nov 2024₩51.5t₩29.4t₩978.5b11.4x52.6x1.8x
Fri, 25 Oct 2024₩60.7t₩28.7t₩833.2b15.1x72.9x2.1x
Sun, 22 Sep 2024₩60.7t₩28.8t₩836.8b15.6x72.5x2.1x
Tue, 20 Aug 2024₩56.9t₩28.4t₩773.0b14.3x73.6x2x
Thu, 18 Jul 2024₩56.2t₩28.4t₩762.2b14.8x73.7x2x
Sat, 15 Jun 2024₩52.1t₩30.2t₩909.9b13.1x57.3x1.7x
Mon, 13 May 2024₩53.9t₩29.7t₩942.1b17.7x57.2x1.8x
Wed, 10 Apr 2024₩51.4t₩29.4t₩922.9b17x55.7x1.7x
Fri, 08 Mar 2024₩52.3t₩29.6t₩593.1b20.5x88.1x1.8x
Sun, 04 Feb 2024₩51.3t₩29.6t₩592.3b21.2x86.6x1.7x
Tue, 02 Jan 2024₩54.8t₩29.6t₩588.2b22.9x93.1x1.8x
Thu, 30 Nov 2023₩48.7t₩29.6t₩612.4b21.2x79.5x1.6x
Sat, 28 Oct 2023₩44.9t₩29.3t₩683.3b15.3x65.8x1.5x
Mon, 25 Sep 2023₩50.1t₩29.3t₩683.3b17.3x73.4x1.7x
Wed, 23 Aug 2023₩50.5t₩29.0t₩721.3b22.3x70x1.7x
Fri, 21 Jul 2023₩48.2t₩28.8t₩899.2b21.8x53.6x1.7x
Sun, 18 Jun 2023₩48.3t₩28.9t₩908.3b21.9x53.1x1.7x
Tue, 16 May 2023₩47.4t₩28.5t₩615.9b19.3x77x1.7x
Thu, 13 Apr 2023₩49.8t₩28.5t₩602.8b19.9x82.7x1.8x
Sat, 11 Mar 2023₩44.5t₩27.8t₩681.9b21.6x65.3x1.6x
Mon, 06 Feb 2023₩46.4t₩27.7t₩743.5b20.4x62.4x1.7x
Wed, 04 Jan 2023₩44.9t₩28.0t₩770.2b19.5x58.3x1.6x
Fri, 02 Dec 2022₩45.3t₩28.0t₩767.5b19.7x59x1.6x
Sun, 30 Oct 2022₩42.2t₩27.2t₩694.8b20.5x60.8x1.5x
Tue, 27 Sep 2022₩41.0t₩27.5t₩720.9b19x56.9x1.5x
Thu, 25 Aug 2022₩48.8t₩26.9t₩503.5b21.9x96.9x1.8x
Sat, 23 Jul 2022₩51.3t₩26.7t₩475.9b22.8x107.9x1.9x
Mon, 20 Jun 2022₩47.2t₩26.7t₩475.9b21.2x99.2x1.8x
Wed, 18 May 2022₩53.0t₩26.1t₩670.0b25.7x79.2x2x
Fri, 15 Apr 2022₩56.1t₩26.1t₩674.3b26.6x83.2x2.2x
Sun, 13 Mar 2022₩55.9t₩25.0t₩927.2b23.7x60.3x2.2x
Tue, 08 Feb 2022₩53.2t₩25.0t₩934.5b22x56.9x2.1x
Price to Earnings Ratio

56.9x


Total Market Cap: ₩53.2tTotal Earnings: ₩934.5bTotal Revenue: ₩25.0tTotal Market Cap vs Earnings and Revenue0%0%0%
South Korean Pharma Industry Price to Earnings3Y Average 70.4x202320242025
Current Industry PE
  • Investors are pessimistic on the South Korean Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 54.8x which is lower than its 3-year average PE of 70.4x.
  • The industry is trading close to its 3-year average PS ratio of 1.8x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 2.8% per year over the last three years.
  • Revenues for these companies have grown 5.8% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the South Korean Healthcare industry?

KR Market-0.70%
Healthcare0.16%
Pharma0.42%
Pharma0.42%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
A000250 Sam Chun Dang Pharm₩184.00k7.0%
+₩279.1b
180.9%PE837.4x
A214370 Caregen₩30.05k6.6%
+₩90.6b
33.3%PE41.1x
A053030 BINEX₩21.85k8.7%
+₩55.7b
113.6%PS5.4x
A069620 Daewoong Pharmaceutical₩137.70k1.6%
+₩25.3b
24.2%PE15.3x
A185750 Chong Kun Dang Pharmaceutical₩86.60k1.3%
+₩14.6b
-17.0%PE6.1x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

A128940

₩244,000.00

Hanmi Pharm

7D

-0.4%

1Y

-23.4%

A001060

₩23,400.00

JW Pharmaceutical

7D

-3.1%

1Y

-25.5%

A003850

₩10,200.00

Boryung

7D

-1.5%

1Y

-15.6%

A170900

₩50,300.00

Dong-A ST

7D

1.2%

1Y

-27.3%

A000100

₩129,600.00

Yuhan

7D

-0.2%

1Y

116.4%

A069620

₩137,700.00

Daewoong Pharmaceutical

7D

1.6%

1Y

24.2%

A047920

₩26,000.00

HLB Pharmaceutical

7D

1.2%

1Y

35.8%